ArticleVeterinary world2026
Use of a synthetic antimicrobial peptide (PA-13) alone or in combination with reduced gentamicin levels to control
Article in Veterinary world, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Bacterial contamination during liquid storage of boar semen negatively affects sperm quality and fertility outcomes, necessitating the routine use of antibiotics in semen extenders. However, increasing concerns regarding antimicrobial resistance have encouraged the development of alternative antimicrobial strategies. Synthetic antimicrobial peptides (AMPs) have demonstrated broad-spectrum antibacterial activity and may serve as potential substitutes or adjuncts to conventional antibiotics. This study aimed to evaluate the antimicrobial efficacy of the synthetic peptide PA-13 alone and in combination with reduced gentamicin concentrations against Materials and Methods: Two experiments were conducted. In Experiment I, fresh semen samples collected from seven healthy adult boars were diluted in Beltsville Thawing Solution supplemented with gentamicin (200 μg/mL, positive control), without antibiotics (negative control), or PA-13 at concentrations of 62.5, 31.25, and 15.625 μg/mL. Total bacterial counts were measured at 0, 24, 48, and 72 h of storage, while semen quality parameters, including sperm motility, viability, acrosomal integrity, and mitochondrial membrane potential, were evaluated on days 1, 3, and 5. In Experiment II, isolated Results: PA-13 effectively inhibited bacterial proliferation in extended semen during the first 24 h of storage, with lower concentrations (15.625 and 31.25 μg/mL) showing greater antibacterial activity than the higher concentration (62.5 μg/mL). Semen quality parameters were comparable among groups on day 1; however, prolonged storage demonstrated that the highest PA-13 concentration negatively affected sperm motility and viability. Lower PA-13 concentrations preserved semen quality similar to that of the gentamicin-treated control. In Experiment II, combination treatments exhibited synergistic effects, with PA-13 at 3.906 μg/mL combined with gentamicin at 100 μg/mL inhibiting Conclusion: PA-13 effectively controls bacterial contamination in stored boar semen while maintaining semen quality at appropriate concentrations. Its combination with gentamicin enables a substantial reduction in antibiotic dosage without compromising antibacterial efficacy. These findings support the use of AMPs as alternative or complementary antimicrobial agents in semen extenders to reduce antibiotic use in the swine industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.